• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄对阿芬太尼的药效学没有影响。

Age has no effect on the pharmacodynamics of alfentanil.

作者信息

Lemmens H J, Bovill J G, Hennis P J, Burm A G

机构信息

Department of Anesthesiology, University Hospital, Leiden, The Netherlands.

出版信息

Anesth Analg. 1988 Oct;67(10):956-60.

PMID:3138925
Abstract

Effects of age on the pharmacodynamics of alfentanil, as a supplement to nitrous oxide anesthesia, were studied in younger (31-52 years; n = 14) and older (56-86 years; n = 14) women undergoing curative surgery for primary breast cancer. Plasma alfentanil concentration-effect curves for perioperative stimuli and for the probability of needing naloxone at the end of the operation were fitted by logistic regression. Effects of age on the plasma concentration-effect relation of alfentanil could not be demonstrated. However, the dose requirement in the older patient group was significantly lower than in the younger patient group.

摘要

作为一氧化二氮麻醉的补充,研究年龄对阿芬太尼药效学的影响,研究对象为接受原发性乳腺癌根治性手术的年轻女性(31 - 52岁;n = 14)和年长女性(56 - 86岁;n = 14)。通过逻辑回归拟合围手术期刺激的血浆阿芬太尼浓度 - 效应曲线以及手术结束时需要纳洛酮的概率。未证实年龄对阿芬太尼血浆浓度 - 效应关系的影响。然而,老年患者组的剂量需求显著低于年轻患者组。

相似文献

1
Age has no effect on the pharmacodynamics of alfentanil.年龄对阿芬太尼的药效学没有影响。
Anesth Analg. 1988 Oct;67(10):956-60.
2
Pharmacodynamics of alfentanil as a supplement to nitrous oxide anaesthesia in the elderly patient.阿芬太尼作为老年患者氧化亚氮麻醉辅助用药的药效学
Br J Anaesth. 1988 Aug;61(2):173-9. doi: 10.1093/bja/61.2.173.
3
Plasma concentrations of alfentanil required to supplement nitrous oxide anaesthesia for lower abdominal surgery.用于下腹部手术补充氧化亚氮麻醉所需的阿芬太尼血浆浓度。
Br J Anaesth. 1983;55 Suppl 2:191S-197S.
4
Ventilatory effects of nitrous oxide during continuous infusion of fentanyl or alfentanil.持续输注芬太尼或阿芬太尼期间氧化亚氮的通气效应。
Eur J Anaesthesiol. 1984 Dec;1(4):345-52.
5
The pharmacokinetics and clinical effects of a low dose of alfentanil in elderly patients.小剂量阿芬太尼在老年患者中的药代动力学及临床效应
Acta Anaesthesiol Belg. 1988;39(1):25-33.
6
A clinical trial of alfentanil as an adjuvant for short anaesthetic procedures.一项关于阿芬太尼作为短时间麻醉手术辅助药物的临床试验。
Br J Anaesth. 1983;55 Suppl 2:173S-178S.
7
Ventilatory depression during and after infusion of alfentanil in man.人体输注阿芬太尼期间及之后的通气抑制
Br J Anaesth. 1983;55 Suppl 2:217S-222S.
8
The clinical pharmacology of alfentanil.阿芬太尼的临床药理学。
Eur J Anaesthesiol Suppl. 1987;1:3-11.
9
Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation.芬太尼和阿芬太尼剂量需求随年龄降低。一项药代动力学和药效学同步评估。
J Pharmacol Exp Ther. 1987 Jan;240(1):159-66.
10
The influence of hepatic plasma flow on alfentanil plasma concentration plateaus achieved with an infusion model in humans: measurement of alfentanil hepatic extraction coefficient.
Anesth Analg. 1986 Oct;65(10):999-1003.

引用本文的文献

1
Clinically important drug interactions with intravenous anaesthetics in older patients.老年患者中静脉麻醉药的临床重要药物相互作用。
Drugs Aging. 2003;20(13):969-80. doi: 10.2165/00002512-200320130-00002.
2
Target-controlled infusion systems: role in anaesthesia and analgesia.靶控输注系统:在麻醉和镇痛中的作用。
Clin Pharmacokinet. 2000 Feb;38(2):181-90. doi: 10.2165/00003088-200038020-00003.
3
Pharmacokinetic-pharmacodynamic relationships for opioids in balanced anaesthesia.平衡麻醉中阿片类药物的药代动力学-药效学关系
Clin Pharmacokinet. 1995 Oct;29(4):231-42. doi: 10.2165/00003088-199529040-00003.
4
Modification of the haemodynamic responses to induction of anaesthesia and tracheal intubation with alfentanil, esmolol and their combination.阿芬太尼、艾司洛尔及其联合应用对麻醉诱导和气管插管血流动力学反应的影响
Can J Anaesth. 1995 Apr;42(4):298-304. doi: 10.1007/BF03010706.
5
Influence of age on the pharmacokinetics of alfentanil. Gender dependence.年龄对阿芬太尼药代动力学的影响。性别依赖性。
Clin Pharmacokinet. 1990 Nov;19(5):416-22. doi: 10.2165/00003088-199019050-00005.